Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval SALT LAKE CITY, June 18, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the...

Nu-Med Plus Reports Spike in International Interest from Physicians, Distributors, and Potential Strategic Partners SALT LAKE CITY, April 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, reports an increase in strategic...

Nu-Med Plus Announces Keith L. Merrell as their full-time Chief Financial Officer and Secretary/Treasurer SALT LAKE CITY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB:NUMD), a medical device company which explores and develops medical applications of new disruptive technologies in the...

Nu-Med Plus, Inc. announces trading on OTCQB Marketplace SALT LAKE CITY, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB:NUMD), a medical device development company announced it has begun to have its securities designated and traded as OTCQB...

Franklin Innovation joins NU-MED PLUS development team for FDA submission of Nitric Oxide Hospital Medical Device SALT LAKE CITY, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB:NUMD), a medical device company which investigates and develops applications of Nitric Oxide technologies in the medical...